Success in the call of the Medical Research Agency – 15 million PLN (3 500 000 €) for development of new methods for lung cancer diagnostics
Lung cancer is the most common cause of death of cancer patients of both genders, while non-small cell lung cancer (NSCLC) accounts for 85% of its cases. NSCLC is a serious problem for the health care system, as the high risk group accounts for 3 million individuals, for whom optimal screening diagnostics is still missing. […]